New World Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$347K Buy
5,553
+1,026
+23% +$64.8K 0.06% 82
2026
Q2
$261K Buy
+4,527
New +$260K 0.04% 91
2019
Q2
– Sell
-1,450
Closed -$69K – 36
2019
Q1
$69K Buy
+1,450
New +$72.2K 0.05% 40

Other funds holding BMY

New World Advisors's BMY Position: Q3 2026 in Review

New World Advisors increased its Bristol-Myers Squibb (BMY) stake by 23% in Q3 2026, buying an estimated $64.8K and bringing the position to 5,553 shares worth $347K. The position accounts for 0.06% of the portfolio, ranked #82.

New World Advisors first reported a position in BMY in Q1 2019 and has held it in 3 quarters since. 2,563 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

  • New World Advisors held 5,553 shares of Bristol-Myers Squibb worth $347K as of Q3 2026.
  • New World Advisors bought 1,026 Bristol-Myers Squibb shares in Q3 2026, an estimated $64.8K.
  • Bristol-Myers Squibb made up 0.06% of New World Advisors's portfolio in Q3 2026, its #82 holding.
  • New World Advisors first reported a position in Bristol-Myers Squibb in Q1 2019 and has held it in 3 quarters since.
  • 2,563 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on New World Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.